Jeffrey I.
About Jeffrey I.
Jeffrey I. is an Assistant Professor of Medicine and Physician Scientist at Yale University, focusing on melanoma and immunotherapy. He has a strong background in immunology, having studied at prestigious institutions and worked in various roles in cancer research and clinical practice.
Current Position at Yale University
Jeffrey I. serves as an Assistant Professor of Medicine and Physician-Scientist at Yale University. He is affiliated with the Pi Ishizuka Lab, where he focuses on advancing research in cancer immunology. His role involves both teaching and conducting research aimed at developing new therapeutic options for patients, particularly in the field of melanoma and immunotherapy.
Educational Background
Jeffrey I. has a comprehensive educational background in the medical and scientific fields. He earned his Doctor of Medicine (MD) from Harvard University, completing his studies from 2008 to 2013. Prior to that, he studied at the University of Oxford, where he obtained a Doctor of Philosophy (DPhil) in Immunology from 2004 to 2008. He also holds a Bachelor of Arts (BA) in Chemistry from Williams College, which he completed from 2000 to 2004.
Clinical Focus and Research Interests
Jeffrey I. specializes in melanoma and immunotherapy, with a particular emphasis on CD8+ T-cell immunodominance and cross-reactivity. His research aims to leverage fundamental discoveries in cancer immunology to create innovative therapeutic strategies for patients. He has developed expertise in functional genomics, viral immunology, cancer immunotherapy, clinical oncology, and RNA editing.
Professional Experience
Jeffrey I. has held various positions throughout his career. He worked as a Graduate Student at the National Institutes of Health for one year from 2007 to 2008. He completed his residency as a Physician at Brigham and Women's Hospital from 2013 to 2015 and served as a Fellow at Dana-Farber Cancer Institute from 2015 to 2019. Additionally, he worked as a Consultant at Jounce Therapeutics, Inc. from 2012 to 2014, and has been a Venture Intern at Third Rock Ventures since 2011.